Another Eye Care blunder

but Cequa actually didn’t try for a generic. They came out with a more efficient delivery system and increased the concentration which is not interchangeable at the pharmacy and is different altogether. They do have a good product with no coverage but we could legitimately have a generic at any time. No one knows.

 

Thanks for the positive spin

 

Off patent for while #doyourhimework

 

More efficient delivery system? Good product? LMAO! Is this from an Allergan rep who got downsized and now works at Sun? Gotta be kidding me.

 

We should move to our new page. Cequa is unique. Don’t be brainwashed.

 

SUN has nothing original or unique. And the numbers show! Lmao

 

The numbers we get are inaccurate because we don’t get specialty pharmacy numbers.

 

Wherever you get your information you are incorrect.

 

Yes off patent with no market generic in sight. Think reatasis has been “going generic” for 4 years.

 

Durysta uptake is concerning. I understand we have had Covid to deal with but still feel nervous.

 

Are you a Durysta rep or just concerned for the company or launch?

 

Is one our drugs performing poorly? Humira will pick up your slack.

 

We all do better when we work together

 

Possibly

 

Drop team needs to quit pushing back on Durysta

 

I hate to hear that we are struggling with durysta. There was a lot of excitement around it.

 

there’s not enough orders or performance around Durysta, the drops reps have nothing to do with it lmao

sounds like this is written by a Durysta rep who’s ranked at the bottom

 

I agree but it isn’t blowing the doors down

 

yeah! Maybe the newbie Durysta team should actually work with the drops reps with who they already have relationships and access with. Rogue Durysta reps not caring about drops/clinic or current drops reps isn’t great to grow the business.

 

This is so true